# Aspirin Treatment for Small Unruptured InTracranial Aneurysms With Ischemic cereBrovascuLar diseasE

Study · id `cardio:ct-nct05907902` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05907902](<https://clinicaltrials.gov/study/NCT05907902>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05907902

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 824 participants.

## Technical summary

Registry record NCT05907902. Randomized; single masking; primary purpose treatment. Start 2023-07-01 (anticipated); primary completion 2025-07-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 824 participants (planned count; ClinicalTrials.gov record NCT05907902, source copy `cardio:ctgov-nct05907902-2023-06-18`, retrieved 2026-11-18)
- Planned start: 2023-07-01 (anticipated) (ClinicalTrials.gov record NCT05907902, source copy `cardio:ctgov-nct05907902-2023-06-18`, retrieved 2026-11-18)
- Primary completion: 2025-07-01 (anticipated) (ClinicalTrials.gov record NCT05907902, source copy `cardio:ctgov-nct05907902-2023-06-18`, retrieved 2026-11-18)
- Completion: 2025-07-01 (anticipated) (ClinicalTrials.gov record NCT05907902, source copy `cardio:ctgov-nct05907902-2023-06-18`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT05907902, source copy `cardio:ctgov-nct05907902-2023-06-18`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05907902-2023-06-18`, retrieved 2026-11-18)

## The registry's words

- Brief title: Aspirin Treatment for Small Unruptured InTracranial Aneurysms With Ischemic cereBrovascuLar diseasE
- Acronym: AT-SUITABLE
- Condition: Intracranial Aneurysm
- Condition: Cerebrovascular Disease
- Intervention (Drug): Aspirin Enteric-coated Tablets
- Lead sponsor: Beijing Tiantan Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Brain aneurysm (intracranial aneurysm) (`cardio:intracranial-aneurysm`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Aspirin (`core:aspirin`)
- Registry lists this organization as the lead sponsor: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)

## Provenance

Content hash: 1b9c4eca1959c3e6b9f3e5d933f1086a19f2277b736f1e2bf2a6c6fe850a82e4
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
